Hikma Pharmaceuticals Acquires Custopharm from Water Street Healthcare Partners

Noramco Acquires Cambrex Drug Product Business Unit (Halo Pharmaceuticals)

November 2, 2023

Pharmaceuticals

Noramco has completed the acquisition of the Cambrex Drug Product Business Unit (previously Halo Pharmaceuticals), adding drug product formulation development, clinical and commercial manufacturing, and packaging capabilities from sites in Mirabel, Québec and Whippany, New Jersey. The purchase expands Noramco's service offering beyond APIs, brings nearly 400 employees into the Noramco group, and represents Cambrex's strategic divestiture to focus on its drug substance and analytical testing businesses.

Water Street Healthcare Partners Invests in Avantik

February 15, 2023

Healthcare Services

Avantik has partnered with Water Street Healthcare Partners, which has committed growth capital and sector experience to support Avantik's next phase of expansion. The investment will fund organic initiatives and acquisitions to expand Avantik's consumables, equipment and maintenance services; Mark Zacur was appointed CEO to lead the growth plan.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Water Street Healthcare Partners Acquires Pillr Health from Renovus Capital Partners

January 20, 2026

Healthcare Services

Water Street Healthcare Partners has acquired Pillr Health from Renovus Capital Partners, marking a full exit for Renovus after a seven-year transformation of the business into a scaled, technology-enabled pharmacy optimization platform. Pillr Health will remain led by its existing management team and is expected to expand under Water Street’s healthcare-focused platform build strategy; financial terms were not disclosed.

Pouschine Cook Leads Investment in Curexa Pharmacy

December 4, 2021

Healthcare Services

Pouschine Cook Capital Management led a growth investment in Curexa Pharmacy, a PCAB-accredited 503A compounding pharmacy that partners with direct-to-consumer telemedicine brands. Institutional co-investors included ORIX Corporation USA’s Private Equity Solutions group and Hexagon; First Horizon Bank provided senior credit facilities and management completed a meaningful rollover to support continued scaling of Curexa’s digital and pharmacy infrastructure.

H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals

December 13, 2021

Pharmaceuticals

An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.